Related Experiment Video
Updated: Apr 26, 2026

10:32
Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease
Published on: June 17, 2013
56.9K
Tetranectin knockout mice develop features of Parkinson disease
Er-song Wang1, Xiao-ping Zhang, Hui-bin Yao
1Department of Neurosurgery, Jinshan Hospital, Fudan University, Shanghai, China.
Summary
Mice lacking tetranectin (TN) developed Parkinson disease (PD) symptoms, including motor deficits and Lewy body-like inclusions. This new TN(-/-) mouse model aids Parkinson disease research.
Area of Science:
- Neuroscience
- Genetics
- Pathology
Background:
- Alpha-synuclein aggregation into Lewy bodies (LBs) is implicated in Parkinson disease (PD) pathogenesis.
- Loss of midbrain dopaminergic neurons is a hallmark of PD.
- A lack of suitable animal models hinders the study of LB formation and PD.
Purpose of the Study:
- To establish and characterize a novel mouse model for Parkinson disease.
- To investigate the role of tetranectin (TN) in PD pathogenesis.
- To evaluate the utility of the TN(-/-) mouse model for studying LB formation and neuroprotection.
Main Methods:
- Generation of a tetranectin (TN) gene knockout mouse model (TN(-/-)).
- Assessment of behavioral and histopathological features relevant to PD.
- Analysis of motor deficits, LB-like inclusions, dopaminergic neuron counts, and dopamine terminal loss.
Main Results:
- Aged TN(-/-) mice exhibited motor impairments, including rigidity and bradykinesia.
- TN(-/-) mice showed increased α-synuclein-positive LB-like inclusions in the substantia nigra pars compacta (SNc).
- Reduced SNc dopaminergic neurons and dorsal striatum dopamine terminals were observed in TN(-/-) mice compared to wild type.
Conclusions:
- The TN(-/-) mouse model recapitulates key pathological and clinical features of Parkinson disease.
- This model provides a valuable tool for investigating LB formation mechanisms.
- The TN(-/-) mouse is suitable for testing potential neuroprotective therapies for PD and other synucleinopathies.
Related Concept Videos
Parkinson Disease ll: Pathophysiology
20
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
20
In-vitro Mutagenesis
14.8K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
14.8K
Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K

